This inventor holds 1 USPTO granted patent. Top assignee: Polymun Scientific Immunbiologische Forschung Gmbh. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Dietmar Katinger: Innovator in Influenza Vaccine Development
Introduction
Dietmar Katinger is a prominent inventor based in Vienna, Austria. He is known for his significant contributions to the field of immunology, particularly in the development of vaccines. His innovative work has led to advancements in the production of live attenuated influenza vaccines.
Latest Patents
Katinger holds a patent for a live attenuated influenza vaccine. This invention relates to a simple and efficient process for isolating viruses from various sources and for producing live attenuated influenza vaccines in a serum-free Vero cell culture. The process minimizes or prevents alterations in the surface antigens of the virus due to adaptive selection. Notably, it does not require purification of the virus-containing supernatant harvested from the cell culture nor post-incubation treatment of the viruses for HA activation. The invention also includes influenza A and B master strain candidates and the vaccines made from them.
Career Highlights
Dietmar Katinger is associated with Polymun Scientific Immunbiologische Forschung GmbH, where he continues to work on innovative solutions in vaccine development. His expertise and dedication to research have made him a valuable asset in the field of immunobiology.
Collaborations
Katinger has collaborated with notable colleagues, including Andre Egorov and Hermann W Katinger. These partnerships have contributed to the advancement of research and development in vaccine technology.
Conclusion
Dietmar Katinger's work in the field of influenza vaccine development showcases his commitment to improving public health through innovative solutions. His contributions are vital in the ongoing fight against influenza and highlight the importance of research in immunology.